By Puyaan Singh
Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in San Francisco.
"CVS has confirmed their coverage of Yeztugo as of January 1, putting us at more than 80% (insurer) coverage overall," O'Day said.
In August, Reuters reported that CVS had not added the drug to its plans based on clinical, financial, and regulatory factors, despite the medicine's proven effectiveness. The twice-yearly injection costs nearly $30,000 a year.
The three largest pharmacy benefit managers, CVS Caremark, UnitedHealth Group's Optum RX and Cigna's Express Scripts, control about 70% of specialty drug prescriptions in the U.S.
Gilead, its investors and AIDS activists have high hopes for Yeztugo. Approved in June for people at high risk of HIV, the drug was shown to be nearly 100% effective at preventing infection in large trials, fueling fresh optimism about limiting the spread of the deadly virus.
O'Day said the company has reached its forecast of sales worth $150 million in 2025, after the drug's launch in the middle of the year.
He also said lenacapavir, the active ingredient in Yeztugo, "was delivered for the first time ever in a Sub-Saharan African country at the end of last year, in the same year as it was introduced in the United States."
O'Day said two-thirds of HIV cases are in Sub-Saharan Africa.
Shares of Gilead were up 1.5% in afternoon trading.
(Reporting by Puyaan Singh in Bengaluru; Editing by Sahal Muhammed)
LATEST POSTS
- 1
Figure out How to Augment the Advantages of a Web-based Degree - 2Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
- 36 Hints to Upgrade Your Appeal, In addition to Your Outlook
- 49 Under-The-Radar Malaysian Islands To Consider Instead Of Thailand Or Indonesia
- 5L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- The most effective method to Explore Moral Situations in Brain research with Your Certification
- As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
- Ancient fire discovery marks significant milestone in human history
- 21 Incredibly Interesting Contemplations To Observe Consistently
- An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- People with depression can treat themselves at home with new device
- Exclusive new photos from 'Michael' biopic show Jaafar Jackson as King of Pop
